PAPILLARY TUMOUR OF RENAL PELVIS

PAPILLARY TUMOUR OF RENAL PELVIS was reported 12 times

PAPILLARY TUMOUR OF RENAL PELVIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Phosphodiesterase 3 Inhibitor [EPC] 1 0.0002
1 Purine Antimetabolite [EPC] 1 0.0000
2 Sulfonylurea [EPC] 1 0.0000
3 Folate Analog Metabolic Inhibitor [EPC] 3 0.0000
4 Aldosterone Antagonist [EPC] 1 0.0000
5 Thiazide Diuretic [EPC] 1 0.0000
6 Vitamin D [EPC] 1 0.0000
7 Vitamin B12 [EPC] 1 0.0000
8 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
9 Vitamin C [EPC] 1 0.0000
10 Corticosteroid [EPC] 3 0.0000
11 Kinase Inhibitor [EPC] 1 0.0000
12 Platelet Aggregation Inhibitor [EPC] 1 0.0000
13 Tumor Necrosis Factor Blocker [EPC] 1 0.0000
14 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000